中文簡(jiǎn)體
中文簡(jiǎn)體
English
HOME
ABOUT US
Company Profile
Company Culture
Company Honor
R&D
Technology Platform
Pipelines
NEWS
Press Release
Awards
CAREERS
CONTACT US
中文簡(jiǎn)體
中文簡(jiǎn)體
English
Search
/uploads/image/img/banner-txt-en-03.svg
首頁(yè)
-
NEWS
Press Release
Awards
Press Release
Awards
U.S. FDA Formally Accepts Beihai Biotech's New Drug Application for Innovative Oncology Drug BH009 (BEIZRAY?)
2024-01-04
Beihai Biotech Founder Dr. Sun Invited to Keynote 'Wisdom in China' Summit at Renmin University Business School
2023-12-26
Beihai Biotech Successfully Concludes Series C Funding, Expediting BH009 Commercialization and Advancing Clinical Trials for Innovative Drug Candidates
2023-12-19
Beihai Biotech Listed Among "Top 100 High-Growth Enterprises in the Greater Bay Area 2023"
2023-11-09
Innovation Recognized Again: Beihai Biotech Honored with GHP “Most Innovative Clinical-Stage Biopharmaceutical Company 2023”
2023-08-01
Beihai Biotech Secures “Drug Manufacturing Certificate”
2023-06-15
Landmark Clinical Research Findings of Beihai Biotech's BH009 Unveiled at ASCO 2023
2023-06-12
Beihai Biotech Earns a Spot on the “China Future Healthcare Rankings 2023-Top 100 Biomedicine Companies”
2023-05-08
<<
1
2
3
4
5
>>
ABOUT US
R&D
NEWS
CAREERS
CONTACT US
Contact Information
Company address:Blg 2, No. 6366, Zhuhai Ave., Jinwan, Zhuhai, 519090, China
Tel:0756-6349669
Human resources contact:hr@bayhibiotech.com
Business cooperation contact:hjiang@bayhibiotech.com
Wechat Official Account
Copyright ? 2023 Zhuhai Beihai Biotech Co., Ltd.
Copyright Registration No. :
Guangdong ICP for 17134092
Technical support :
Xiangxun Technology
亚洲国产精品一区-国产精品伦子一区二区三区-国产a级一级毛片-亚洲日韩视频一区二区在线观看-99久久国产热无码精品免费